AI tool to speed up diagnosis of rare immune diseases

Researchers at VIB and UGent, alongside clinicians at UZ Gent, have developed an AI tool that can speed up the diagnosis of rare immune diseases. The technology analyses complex laboratory data and helps doctors make faster and more focused diagnoses.

The help of AI is especially useful for rare diseases, as doctors see such conditions less frequently and therefore find it harder to recognise them. The technology can detect patterns in data that are less obvious to the human eye.

Primary immune deficiencies are rare conditions in which the immune system does not function properly. Some forms, such as severe combined immune deficiency, can be life-threatening if not detected in time. Diagnosis is often complex and relies heavily on specialised expertise.

"It will allow us to critically evaluate the results and integrate them responsibly into clinical decision-making"

The new AI tool, PIDgeon, automates an important part of that analysis. It processes standardised data from flow cytometry studies, detects abnormalities in immune cells and suggests possible disease states. In the process, it generates interpretable reports so doctors can understand what the analysis is based on.

“The explainable nature of the system is essential,” says Professor Carolien Bonroy, clinical biologist at Ghent University Hospital. “It will allow us to critically evaluate the results and integrate them responsibly into clinical decision-making. We look forward to applying it in practice.”

Website preview
Cancer survival reaches record high as personalised therapies advance
Research into personalised immunotherapy could eventually ensure that many cancers are no longer fatal, according to Belgium’s Foundation Against...
belganewsagency.eu

The technology was validated on nearly 1,000 patients from several European centres. The results show that the tool achieves high accuracy and is particularly sensitive in detecting severe abnormalities in T cells in the blood.

According to the researchers, the application is intended as a decision support tool. It should help doctors make diagnoses faster and prioritise urgent cases, without replacing their expertise. PIDgeon is not yet available for use in clinical practice.

 

#FlandersNewsService | © PHOTO VIB / INE DEHANDSCHUTTER


Related news

Website preview
Legend Biotech named Flanders' Foreign Investor of the Year for Ghent expansion
The US biotechnology company Legend Biotech has been awarded Foreign Investor of the Year by Flanders Investment & Trade (FIT). The company...
belganewsagency.eu
Website preview
Flemish biotech institute joins EU coalition to boost investment
The Flanders Institute for Biotechnology (VIB) is joining the newly established European Life Sciences Coalition (ELSC), a partnership designed to...
belganewsagency.eu

Share

Get updates in your mailbox

By clicking "Subscribe" I confirm I have read and agree to the Privacy Policy.

About belganewsagency.eu

Belga News Agency delivers dependable, rapid and high-quality information 24 hours a day, 7 days a week, from Belgium and abroad to all Belgian media. The information covers all sectors, from politics, economics and finance to social affairs, sports and culture, not to mention entertainment and lifestyle.

Every day, our journalists and press photographers produce hundreds of photos and news stories, dozens of online information items, plus audio and video bulletins, all in both national languages. Since the end of March 2022 English has been added as a language.

For public institutions, businesses and various organisations that need reliable information, Belga News Agency also offers a comprehensive range of corporate services to meet all their communication needs.

Contact

Arduinkaai 29 1000 Brussels

www.belganewsagency.eu